Your Location:
Home >
Browse articles >
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease
RESEARCH | Updated:2025-12-13
Previous|Next
    • Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease

    • “In the field of metabolic dysfunction-associated fatty liver disease (MAFLD), researchers have established a causal relationship between KIF13B deficiency and MAFLD, laying a foundation for the construction of a potential therapeutic target for treating MAFLD.”
    • Guo-Lin Miao , Wen-Xi Zhang , Yi-Tong Xu , Yi-Ran Liu , Ping-Ping Lai , Jia-Bao Guo , Gong-Lie Chen , Jing-Xuan Chen , Zi-Hao Zhou , Yan-Wei Li , Chong Zhang , Yang Ding , Lian-Xin Zhang , Yu-Fei Han , Jin-Xuan Chen , Jing-Dong Wu , Yin-Qi Zhao , Si Mei , Yang Zhao , Yuan-Wu Ma , Ling Zhang , Wei Huang , Dong-Yu Zhao , Er-Dan Dong , Yu-Hui Wang , Xun-De Xian
    • Military Medical Research Vol. 12, Issue 9, Pages: 1329-1349(2025)
    • DOI: 10.1186/s40779-025-00594-3     

      CLC:
    • Accepted:16 January 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 8 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

135

Views

103

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Advanced multifunctional nano-delivery platform focusing on treating diseases related to lipid metabolism via targeted intervention in various lipid metabolic processes
RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Related Author

Xun-De Xian
Yu-Hui Wang
Er-Dan Dong
Dong-Yu Zhao
Ying Sun
Kai Yan
Yi Zhang
Yan-Qi Han

Related Institution

Translational Medicine Center, Beijing Chest Hospital, Capital Medical University
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences &Peking Union Medical College
Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
Children Hospital of Fudan University
Department of Neurosurgery, Renmin Hospital of Wuhan University